Medical prophylaxis and treatment of cystoid macular edema after cataract surgery. The results of a meta-analysis
- PMID: 9499767
- DOI: 10.1016/S0161-6420(98)93018-4
Medical prophylaxis and treatment of cystoid macular edema after cataract surgery. The results of a meta-analysis
Abstract
Objective: The study aimed to determine the effectiveness of prophylactic medical intervention in reducing the incidence of cystoid macular edema (CME) and the effectiveness of medical treatment for chronic CME after cataract surgery.
Design: The study design was a systematic review and meta-analysis of published reports of randomized clinical trials (RCTs).
Participants: Sixteen RCTs involving 2898 eyes examining the effectiveness of medical prophylaxis of CME and 4 RCTs involving 187 eyes testing the effectiveness of medical treatment of chronic CME were used in the study.
Interventions: Medical prophylaxis of treatment (cyclo-oxygenase inhibitors or corticosteroids) versus control (placebo or active treatment) was performed.
Main outcome measures: Incidence of angiographically diagnosed CME, incidence of clinically significant CME, and vision were measured.
Results: Thirty-six articles reported testing a prophylactic medical intervention for CME after cataract surgery. The incidence of CME varied extensively across studies and was related to the study design used. Summary odds ratios (OR) indicated that prophylactic intervention was effective in reducing the incidence of both angiographic CME (OR = 0.36; 95% confidence interval [CI] = 0.28-0.45) and clinically relevant CME (OR = 0.49; 95% CI = 0.33-0.73). There also was a statistically significant positive effect on improving vision (OR = 1.97; 95% CI = 1.14-3.41). A combination of the results of the four RCTs testing medical therapy for chronic CME indicated a treatment benefit in terms of improving final visual acuity by two or more Snellen lines (OR = 2.67; 95% CI = 1.35-5.30). Assessment of the quality of the 20 RCTs included in the meta-analyses indicated problems in the design, execution, and reporting of a number of trials.
Conclusion: A combination of the results from RCTs indicates that medical prophylaxis for aphakic and pseudophakic CME and medical treatment for chronic CME are beneficial. Because most of the RCTs performed to date have problems related to quality, a well-designed RCT is needed to confirm this result, using clinical CME and vision as outcomes.
Comment in
-
Prevention and treatment of CME after cataract surgery.Ophthalmology. 1998 Nov;105(11):1985-6; author reply 1986-7. doi: 10.1016/S0161-6420(98)91109-5. Ophthalmology. 1998. PMID: 9818592 No abstract available.
-
Prevention and treatment of CME after cataract surgery.Ophthalmology. 1998 Nov;105(11):1986-7. doi: 10.1016/S0161-6420(98)91110-1. Ophthalmology. 1998. PMID: 9818593 No abstract available.
Similar articles
-
Clinical pseudophakic cystoid macular edema. Risk factors for development and duration after treatment.J Cataract Refract Surg. 2007 Sep;33(9):1550-8. doi: 10.1016/j.jcrs.2007.05.013. J Cataract Refract Surg. 2007. PMID: 17720069
-
Visually significant cystoid macular edema in pseudophakic and aphakic patients with glaucoma receiving latanoprost.J Glaucoma. 2000 Aug;9(4):317-21. doi: 10.1097/00061198-200008000-00006. J Glaucoma. 2000. PMID: 10958605
-
Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema.Ophthalmology. 2000 Nov;107(11):2034-8;discussion 2039. doi: 10.1016/s0161-6420(00)00365-1. Ophthalmology. 2000. PMID: 11054327 Clinical Trial.
-
Treatment of pseudophakic CME.Ocul Immunol Inflamm. 1998 Jun;6(2):121-3. doi: 10.1076/ocii.6.2.121.4053. Ocul Immunol Inflamm. 1998. PMID: 9689642 Review.
-
Pseudophakic cystoid macular edema.Ophthalmologica. 2012;227(2):61-7. doi: 10.1159/000331277. Epub 2011 Sep 15. Ophthalmologica. 2012. PMID: 21921587 Review.
Cited by
-
Bromfenac ophthalmic solution 0.09 %: human aqueous humor concentration detected by high-performance liquid chromatography.Int Ophthalmol. 2017 Apr;37(2):417-421. doi: 10.1007/s10792-016-0279-3. Epub 2016 Jun 20. Int Ophthalmol. 2017. PMID: 27324371
-
Cystoid macular edema after cataract surgery in a patient with previous severe iritis following argon laser peripheral iridoplasty.Clin Ophthalmol. 2011;5:473-6. doi: 10.2147/OPTH.S17202. Epub 2011 Apr 18. Clin Ophthalmol. 2011. PMID: 21573094 Free PMC article.
-
Macular edema after rhegmatogenous retinal detachment repair: risk factors, OCT analysis, and treatment responses.Int J Retina Vitreous. 2021 Jan 25;7(1):9. doi: 10.1186/s40942-020-00254-9. Int J Retina Vitreous. 2021. PMID: 33494835 Free PMC article.
-
Non-steroidal anti-inflammatory agents for cystoid macular oedema following cataract surgery: a systematic review.Br J Ophthalmol. 2005 Nov;89(11):1420-2. doi: 10.1136/bjo.2005.073817. Br J Ophthalmol. 2005. PMID: 16234444 Free PMC article.
-
The role of NSAIDs in the management of postoperative ophthalmic inflammation.Drugs. 2007;67(9):1291-308. doi: 10.2165/00003495-200767090-00004. Drugs. 2007. PMID: 17547472 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical